Table of Contents
Volume 1 | Supplement 1
Publication Date: April 2000- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Contributions | ||
S5-S9 |
Single-Agent Docetaxel (Taxotere®) in the Treatment of Advanced Non–Small-Cell Lung Cancer: Clinical Concepts and Commentary Scott A. Laurie, Mark G. Kris |
|
S10-S14 |
Docetaxel in Combination with Platinum Compounds for Non–Small-Cell Lung Cancer Chandra P. Belani |
|
S15-S19 |
Docetaxel and Gemcitabine: A Nonplatinum Combination for Non–Small-Cell Lung Cancer Anthony J. Olszanski, James R. Rigas |
|
S20-S23 |
Docetaxel and Gemcitabine Combinations in Chemotherapy-Pretreated Non–Small-Cell Lung Cancer C. Harris Spiridonidis, Leslie R. Laufman |
|
S24-S26 |
Trials of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer Vincent A. Miller |
|
S27-S31 |
A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial H. Choy, R.F. DeVore, K.R. Hande, L.L. Porter, P.A. Rosenblatt, B. Slovis, K. Laporte, Y. Shyr, D.H. Johnson |
|